Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SILTUXIMAB vs SIROLIMUS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SILTUXIMAB vs SIROLIMUS: Safety Overview

Metric SILTUXIMAB SIROLIMUS
Total FAERS Reports 472 11,371
Deaths Reported 89 1,737
Death Rate 18.9% 15.3%
Hospitalizations 145 3,535
Average Patient Age 47.4 yrs 43.1 yrs
% Female Patients 56.9% 45.4%
FDA Approval Date N/A Aug 22, 2002
Manufacturer Recordati Rare Diseases, Inc. Zydus Lifesciences Limited
Route INTRAVENOUS ORAL
Marketing Status Prescription Prescription